HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

respiratory syncytial virus immune globulin intravenous

indicated for the prevention of serious RSV (respiratory syncytial virus) infection in infants
Also Known As:
RSV-IGIV; Respigam
Networked: 20 relevant articles (3 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: 2 articles (12/2003 - 12/2003)
2. Pfarr, D S: 1 article (01/2008)
3. Losonsky, G A: 1 article (01/2008)
4. Kiener, P A: 1 article (01/2008)
5. Wu, H: 1 article (01/2008)
6. Meissner, H Cody: 1 article (12/2003)
7. Long, Sarah S: 1 article (12/2003)
8. Sepkowitz, K A: 1 article (02/2002)
9. Kiehn, T E: 1 article (02/2002)
10. Ushay, H M: 1 article (02/2002)

Related Diseases

1. Infection
2. Bronchopulmonary Dysplasia
3. Heart Diseases (Heart Disease)
4. Respiratory Syncytial Virus Infections
5. Respiratory Tract Infections (Respiratory Tract Infection)

Related Drugs and Biologics

1. palivizumab
2. Neutralizing Antibodies
3. Intravenous Immunoglobulins (IVIG)
4. Cyclophosphamide (Cytoxan)
5. respiratory syncytial virus immune globulin intravenous
6. Immunoglobulins (Immunoglobulin)
7. Ribavirin (Virazole)
8. Vaccines
9. Oxygen
10. gamma-Globulins (gamma-Globulin)

Related Therapies and Procedures

1. Length of Stay